de Boer A - Search Results

1

Detection of drug interactions with single dose acenocoumarol: new screening method?

Kroon C, de Boer A, Hoogkamer JF, Schoemaker HC, van der Meer EJ, Edelbroek PM, Cohen AF. Kroon C, et al. Among authors: de boer a. Int J Clin Pharmacol Ther Toxicol. 1990 Aug;28(8):355-60. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2272718 Clinical Trial.

2

Pronounced effects of the combination of a new thromboxane antagonist (GR32191) and heparin on bleeding time in man.

de Boer A, Kroon JM, Kroon C, van Vliet A, Schoemaker HC, Breimer DD, Donoghue S, Cohen AF. de Boer A, et al. Thromb Haemost. 1992 Jul 6;68(1):24-9. Thromb Haemost. 1992. PMID: 1514168 Clinical Trial.

3

Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

De Boer A, Kluft C, Kasper FJ, Kroon JM, Schoemaker HC, Breimer DD, Soons PA, Cohen AF. De Boer A, et al. Br J Clin Pharmacol. 1993 Aug;36(2):99-104. doi: 10.1111/j.1365-2125.1993.tb04203.x. Br J Clin Pharmacol. 1993. PMID: 8398589 Free PMC article. Clinical Trial.

4

Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.

Kroon C, ten Hove WR, de Boer A, Kroon JM, van der Pol JM, Harthoorn-Lasthuizen EJ, Schoemaker HC, van der Meer FJ, Cohen AF. Kroon C, et al. Among authors: de boer a. Circulation. 1992 Nov;86(5):1370-5. doi: 10.1161/01.cir.86.5.1370. Circulation. 1992. PMID: 1423948 Clinical Trial.

5

Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers.

Krulder JW, de Boer A, van den Besselaar AM, Cohen AF, Schoemaker HC, Briët E, Meinders AE. Krulder JW, et al. Among authors: de boer a. Thromb Haemost. 1992 Jul 6;68(1):30-2. Thromb Haemost. 1992. PMID: 1514169 Clinical Trial.

6

Influence of skinfold thickness on heparin absorption.

Kroon C, de Boer A, Kroon JM, Schoemaker HC, van den Meer FJ, Cohen AF. Kroon C, et al. Among authors: de boer a. Lancet. 1991 Apr 20;337(8747):945-6. doi: 10.1016/0140-6736(91)91573-d. Lancet. 1991. PMID: 1678033 Clinical Trial.

7

Interaction of the combined medication with the new low-molecular-weight heparinoid Lomoparan (Org 10172) and acenocoumarol.

Stiekema JC, de Boer A, Danhof M, Kroon C, Broekmans AW, van Dinther TG, Voerman J, Breimer DD. Stiekema JC, et al. Among authors: de boer a. Haemostasis. 1990;20(3):136-46. doi: 10.1159/000216120. Haemostasis. 1990. PMID: 1696921 Clinical Trial.

8

Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.

de Boer A, Danhof M, Cohen AF, Magnani HN, Breimer DD. de Boer A, et al. Thromb Haemost. 1991 Aug 1;66(2):202-7. Thromb Haemost. 1991. PMID: 1722918 Clinical Trial.

9

Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

Soons PA, De Boer A, Cohen AF, Breimer DD. Soons PA, et al. Among authors: de boer a. Br J Clin Pharmacol. 1991 Dec;32(6):697-704. Br J Clin Pharmacol. 1991. PMID: 1768562 Free PMC article. Clinical Trial.

10

Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.

van den Berg G, van Steveninck F, Gubbens-Stibbe JM, Schoemaker HC, de Boer AG, Cohen AF. van den Berg G, et al. Among authors: de boer ag. Eur J Clin Pharmacol. 1990;39(3):315-6. doi: 10.1007/BF00315121. Eur J Clin Pharmacol. 1990. PMID: 2257873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,399 results

Search Page

Filters